Global Buprenorphine Hydrochloride Market Outlook 2016-2021
- GEN713944
- 121 Pages
- September 2016
- Pharmaceuticals
This report provides detailed analysis of worldwide markets for Buprenorphine Hydrochloride from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Buprenorphine Hydrochloride market and further lays out an analysis of the factors influencing the supply/demand for Buprenorphine Hydrochloride, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.
GCC’s report, Global Buprenorphine Hydrochloride Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Buprenorphine Hydrochloride market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Buprenorphine Hydrochloride market are Sanofi (France), Noramco (Belgium), Siegfried Group (Switzerland), Arevipharma (Germany), Johnson Matthey (UK), Cambrex (USA), Sun Pharmaceutical (India), Resonance Laboratories (India), UNICHEM (India), CNPIC (China), TIPR Pharmaceutical (China), among others.
The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Buprenorphine Hydrochloride industry has been provided.
Part 1. Scope of Report
1.1 Methodology
1.2 Geographic Scope
1.3 Years Considered
Part 2. Introduction
2.1 Definition
2.2 Current Scenario
2.2 Future Scenario
Part.3 Value Chain Analysis
3.1 Upstream
3.2 Downstream
Part 4. Manufacture
4.1 Manufacturing Process
4.2 Issues and Trends
4.3 Manufacturing Costs
Part 5. Worldwide Key Vendors
5.1 Company A
5.1.1 Business Overview
5.1.2 Products Offered
5.1.3 Business Performance
5.2 Company B
5.3 Company C
5.4 Company D
5.5 Company E
5.6 Company F
5.7 Company G
5.8 Company H
5.9 Company I
5.10 Company J
Part 6. Market Overview
6.1 Global Production Volume 2011-2016
6.2 Production Volume by Region 2011-2016
6.2.1 North America
6.2.2 EMEA
6.2.3 Asia-Pacific
6.2.4 ROW
6.3 Global Production Value 2011-2016
6.4 Production Value by Region
6.4.1 North America
6.4.2 EMEA
6.4.3 Asia-Pacific
6.4.4 ROW
Part 7. Consumption Pattern
7.1 Regional Consumption
7.1.1 North America
7.1.2 EMEA
7.1.3 Asia-Pacific
7.1.4 ROW
7.2 Global Consumption by Application
Part 8. Market Forecast
8.1 Market Size by Volume
8.1.1 North America
8.1.2 EMEA
8.1.3 Asia-Pacific
8.1.4 ROW
8.2 Market Size by Value
8.2.1 North America
8.2.2 EMEA
8.2.3 Asia-Pacific
8.2.4 ROW
8.3 Regional Consumption Forecast
8.3.1 North America
8.3.2 EMEA
8.3.3 Asia-Pacific
8.3.4 ROW
8.4 Consumption Forecast by Application
Part 9. Market Dynamics
9.1 Market Drivers
9.2 Market Constraints
9.3 Market Strategies
Part 10 Key Events
10.1 Mergers & Acquisitions
10.2 New Product Launches
10.3 Expansions
10.4 Other Developments
List Of Tables
Figure Global Buprenorphine Hydrochloride Production Volume (Unit) 2011-2016
Figure Global Buprenorphine Hydrochloride Production Value (M USD) 2011-2016
Figure Top 10 Buprenorphine Hydrochloride Vendors Production Volume Share 2015
Figure Top 10 Buprenorphine Hydrochloride Vendors Production Value Share 2015
Figure Regional Buprenorphine Hydrochloride Production (Unit) 2015
Figure Regional Buprenorphine Hydrochloride Production Value (M USD) 2015
Table Raw Material Materials Suppliers
Figure Global Buprenorphine Hydrochloride Consumption Pattern 2015
Figure Manufacturing Cost Structure
Figure Company A Buprenorphine Hydrochloride Products
Table Company A Financial Performance 2011-2016
Figure Company A Market Share 2011-2016
Figure Company B Buprenorphine Hydrochloride Products
Table Company B Financial Performance 2011-2016
Figure Company B Market Share 2011-2016
Figure Company C Buprenorphine Hydrochloride Products
Table Company C Financial Performance 2011-2016
Figure Company C Market Share 2011-2016
Figure Company D Buprenorphine Hydrochloride Products
Table Company D Financial Performance 2011-2016
Figure Company D Market Share 2011-2016
Figure Company E Buprenorphine Hydrochloride Products
Table Company E Financial Performance 2011-2016
Figure Company E Market Share 2011-2016
Figure Company F Buprenorphine Hydrochloride Products
Table Company F Financial Performance 2011-2016
Figure Company F Market Share 2011-2016
Figure Company G Buprenorphine Hydrochloride Products
Table Company G Financial Performance 2011-2016
Figure Company G Market Share 2011-2016
Figure Company H Buprenorphine Hydrochloride Products
Table Company H Financial Performance 2011-2016
Figure Company H Market Share 2011-2016
Figure Company I Buprenorphine Hydrochloride Products
Table Company I Financial Performance 2011-2016
Figure Company I Market Share 2011-2016
Figure Company J Buprenorphine Hydrochloride Products
Table Company J Financial Performance 2011-2016
Figure Company J Market Share 2011-2016
Table Global Key Buprenorphine Hydrochloride Vendors Production (Unit) 2011-2016
Table Global Key Buprenorphine Hydrochloride Vendors Production Share 2011-2016
Figure Global Buprenorphine Hydrochloride Capacity & Production (Unit), Capacity Utilization 2011-2016
Figure Global Top 10 Buprenorphine Hydrochloride Vendors Production (Unit) 2011-2016
Table Global Top 10 Buprenorphine Hydrochloride Vendors Production (Unit) 2011
Table Global Top 10 Buprenorphine Hydrochloride Vendors Production (Unit) 2012
Table Global Top 10 Buprenorphine Hydrochloride Vendors Production (Unit) 2013
Table Global Top 10 Buprenorphine Hydrochloride Vendors Production (Unit) 2014
Table Global Top 10 Buprenorphine Hydrochloride Vendors Production (Unit) 2015
Table Global Top 10 Buprenorphine Hydrochloride Vendors Production (Unit) 2016
Figure Buprenorphine Hydrochloride Production Volume (Unit) 2011-2016
Table Global Production Volume (Unit) 2011-2016
Table Global Production Volume Share 2011-2016
Figure North America Buprenorphine Hydrochloride Capacity & Production (Unit)
Figure North America Production Share Trend
Figure EMEA Buprenorphine Hydrochloride Capacity & Production (Unit)
Figure EMEA Production Share Trend
Figure Asia-Pacific Buprenorphine Hydrochloride Capacity & Production (Unit)
Figure Asia-Pacific Production Share Trend
Figure ROW Buprenorphine Hydrochloride Capacity & Production (Unit)
Figure ROW Production Share Trend Change
Figure Global Buprenorphine Hydrochloride Production Value (M USD), Growth Rate
Table Global Key Buprenorphine Hydrochloride Vendors Production Value (M USD) 2011-2016
Table Global Key Buprenorphine Hydrochloride Vendors Production Value Share 2011-2016
Figure Global Top 10 Buprenorphine Hydrochloride Vendors Production Value (M USD) 2011-2016
Table Global Top 10 Buprenorphine Hydrochloride Vendors Production Value (M USD) 2011
Table Global Top 10 Buprenorphine Hydrochloride Vendors Production Value (M USD) 2012
Table Global Top 10 Buprenorphine Hydrochloride Vendors Production Value (M USD) 2013
Table Global Top 10 Buprenorphine Hydrochloride Vendors Production Value (M USD) 2014
Table Global Top 10 Buprenorphine Hydrochloride Vendors Production Value (M USD) 2015
Table Global Top 10 Buprenorphine Hydrochloride Vendors Production Value (M USD) 2016
Figure Buprenorphine Hydrochloride Prices (USD/Ton) 2016
Figure Buprenorphine Hydrochloride Gross Margin 2016
Figure Buprenorphine Hydrochloride Production Value (M USD) By Region 2011-2016
Table Global Buprenorphine Hydrochloride Production Value (M USD) 2011-2016
Table Global Buprenorphine Hydrochloride Production Value Share 2011-2016
Figure North America Production Value (M USD), Growth Rate
Figure North America Buprenorphine Hydrochloride Production Value Share Trend
Figure EMEA Production Value (M USD), Growth Rate
Figure EMEA Buprenorphine Hydrochloride Production Value Share Trend
Figure Asia-Pacific Production Value (M USD), Growth Rate
Figure Asia-Pacific Buprenorphine Hydrochloride Production Value Share Trend
Figure ROW Production Value (M USD), Growth Rate
Figure ROW Buprenorphine Hydrochloride Production Value Share Trend
Figure Global Buprenorphine Hydrochloride Consumption Volume (Unit) 2015
Table Regional Buprenorphine Hydrochloride Consumption Volume (Unit) 2011-2016
Table Regional Buprenorphine Hydrochloride Consumption Volume Share 2011-2016
Figure Buprenorphine Hydrochloride Consumption in North America 2011-2016
Figure Buprenorphine Hydrochloride Consumption in EMEA 2011-2016
Figure Buprenorphine Hydrochloride Consumption in Asia-Pacific 2011-2016
Figure Buprenorphine Hydrochloride Consumption in ROW 2011-2016
Figure Global Buprenorphine Hydrochloride Consumption Volume (Unit) 2016
Table Global Buprenorphine Hydrochloride Consumption Volume (Unit) 2011-2016
Table Global Buprenorphine Hydrochloride Consumption Volume Share 2011-2016
Figure Global Buprenorphine Hydrochloride Production (Unit) Forecast 2016-2021
Table Global Buprenorphine Hydrochloride Production (Unit) 2016-2021
Table Global Buprenorphine Hydrochloride Production Share 2016-2021
Figure North Buprenorphine Hydrochloride Production (Unit) Forecast 2016-2021
Figure EMEA Buprenorphine Hydrochloride Production (Unit) Forecast 2016-2021
Figure Asia-Pacific Buprenorphine Hydrochloride Production (Unit) Forecast 2016-2021
Figure ROW Buprenorphine Hydrochloride Production (Unit) Forecast 2016-2021
Figure Global Buprenorphine Hydrochloride Revenue (M USD) Forecast 2016-2021
Table Global Buprenorphine Hydrochloride Revenue (M USD) 2016-2021
Table Global Buprenorphine Hydrochloride Revenue Share 2016-2021
Figure North America Buprenorphine Hydrochloride Revenue (M USD) Forecast 2016-2021
Figure EMEA Buprenorphine Hydrochloride Revenue (M USD) Forecast 2016-2021
Figure Asia-Pacific Buprenorphine Hydrochloride Revenue (M USD) Forecast 2016-2021
Figure ROW Buprenorphine Hydrochloride Revenue (M USD) Forecast 2016-2021
Figure Global Buprenorphine Hydrochloride Consumption Volume (Unit) 2016-2021
Table Global Buprenorphine Hydrochloride Consumption Volume (Unit) 2016-2021
Table Global Buprenorphine Hydrochloride Consumption Volume Share 2016-2021
Figure North America Buprenorphine Hydrochloride Consumption (Unit) Forecast
Figure EMEA Buprenorphine Hydrochloride Consumption (Unit) Forecast
Figure Asia-Pacific Buprenorphine Hydrochloride Consumption (Unit) Forecast
Figure ROW Buprenorphine Hydrochloride Consumption (Unit) Forecast
Figure Global Buprenorphine Hydrochloride Consumption Volume (Unit) 2021
Table Global Buprenorphine Hydrochloride Consumption Volume (Unit) 2016-2021
Table Global Buprenorphine Hydrochloride Consumption Volume Share 2016-2021
Table Key Strategies for Buprenorphine Hydrochloride Multinational Corporations
Table Key Strategies for Buprenorphine Hydrochloride Emerging-Market Players
List Of Figures
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
